Insights

Collaborative Partnerships Turn Bio recently partnered with HanAll Biopharma Co., Ltd. to develop eye and ear therapies. This signals potential collaboration opportunities with other biopharma companies looking to leverage Turn Bio's innovative technologies for novel treatments.

Expanding Product Portfolio With the launch of eTurna, a novel delivery platform, Turn Bio has expanded its product offerings beyond mRNA medicines. This diversification opens up opportunities to engage with healthcare providers seeking cutting-edge solutions for various medical conditions.

Reinforced Leadership Team The appointments of Richard Peterson as CFO and Vittorio Sebastiano as Head of Research demonstrate Turn Bio's commitment to strengthening its leadership team. This presents opportunities for business consultants to explore strategic collaborations or services tailored to support a growing biotech company.

Niche Market Penetration Turn Bio's focus on developing medicines to combat age-related diseases highlights its niche market penetration strategy. Sales professionals could target healthcare institutions specializing in geriatric care or anti-aging clinics to introduce Turn Bio's groundbreaking therapies.

Innovative Technology Platform The use of mRNA technology by Turn Bio to develop novel medicines positions the company as a leader in innovative healthcare solutions. This serves as a compelling selling point for business development reps when engaging with potential pharmaceutical partners or investors interested in disruptive biotechnologies.

Turn Biotechnologies Tech Stack

Turn Biotechnologies uses 8 technology products and services including jQuery CDN, Squarespace, Google Font API, and more. Explore Turn Biotechnologies's tech stack below.

  • jQuery CDN
    Content Delivery Network
  • Squarespace
    Content Management System
  • Google Font API
    Font Scripts
  • jQuery
    Javascript Libraries
  • RSS
    Miscellaneous
  • Open Graph
    Miscellaneous
  • Google
    Miscellaneous
  • YouTube
    Video Players

Media & News

Turn Biotechnologies's Email Address Formats

Turn Biotechnologies uses at least 1 format(s):
Turn Biotechnologies Email FormatsExamplePercentage
First.Last@turn.bioJohn.Doe@turn.bio
49%
First.L@turn.bioJohn.D@turn.bio
1%
First.Last@turn.bioJohn.Doe@turn.bio
49%
First.L@turn.bioJohn.D@turn.bio
1%

Frequently Asked Questions

Where is Turn Biotechnologies's headquarters located?

Minus sign iconPlus sign icon
Turn Biotechnologies's main headquarters is located at 319 North Bernardo Ave Mountain View, California 94043 US. The company has employees across 3 continents, including North AmericaAfricaEurope.

What is Turn Biotechnologies's official website and social media links?

Minus sign iconPlus sign icon
Turn Biotechnologies's official website is turn.bio and has social profiles on LinkedIn.

How much revenue does Turn Biotechnologies generate?

Minus sign iconPlus sign icon
As of November 2024, Turn Biotechnologies's annual revenue reached $1.8M.

What is Turn Biotechnologies's SIC code NAICS code?

Minus sign iconPlus sign icon
Turn Biotechnologies's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Turn Biotechnologies have currently?

Minus sign iconPlus sign icon
As of November 2024, Turn Biotechnologies has approximately 30 employees across 3 continents, including North AmericaAfricaEurope. Key team members include Chief Executive Officer: A. K.Chief Financial Officer: R. P.Head Of Immunology: M. T.. Explore Turn Biotechnologies's employee directory with LeadIQ.

What industry does Turn Biotechnologies belong to?

Minus sign iconPlus sign icon
Turn Biotechnologies operates in the Biotechnology Research industry.

What technology does Turn Biotechnologies use?

Minus sign iconPlus sign icon
Turn Biotechnologies's tech stack includes jQuery CDNSquarespaceGoogle Font APIjQueryRSSOpen GraphGoogleYouTube.

What is Turn Biotechnologies's email format?

Minus sign iconPlus sign icon
Turn Biotechnologies's email format typically follows the pattern of . Find more Turn Biotechnologies email formats with LeadIQ.

When was Turn Biotechnologies founded?

Minus sign iconPlus sign icon
Turn Biotechnologies was founded in 2018.
Turn Biotechnologies

Turn Biotechnologies

Biotechnology ResearchCalifornia, United States11-50 Employees

Aging has been called “the emperor of all maladies.” Turn Bio’s goal is to address multiple aging-related indications using a single powerful reprogramming therapy that turns old cells young again, aiding in the rejuvenation of an aged human body.

In 2013, a paper in Cell (The hallmarks of aging, López-Otin et al.,) proposed nine key “Hallmarks of Aging” that are causes of the general phenotype we refer to as “aging.” Our team recognized that it would be necessary to “turn back the clock” on each of these hallmarks and so set out to develop the technology to do just that. The task was achieved by a using a proprietary cocktail of transiently-administered rejuvenation factors that have now been shown to reverse eight of the nine hallmarks.

Join us as we embark on the task to "turn back time."​

Section iconCompany Overview

Headquarters
319 North Bernardo Ave Mountain View, California 94043 US
Website
turn.bio
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
11-50

Section iconFunding & Financials

  • $10M

    Turn Biotechnologies's revenue is in the range of $10M

Section iconFunding & Financials

  • $10M

    Turn Biotechnologies's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.